Navigation Links
Syntermed licenses Emory ERTb software for enhanced cardiac imaging
Date:9/11/2008

A comprehensive software package designed to significantly improve the quality and accessibility of nuclear cardiology images has been licensed by Emory University to Syntermed, an Atlanta-based nuclear medicine imaging and informatics software company. The software, called the Emory Reconstruction Toolbox™ (ERTb™), was developed by Emory medical scientists Ernest Garcia, PhD, and Ji Chen, PhD, and their colleagues through a grant from the Georgia Research Alliance (GRA).

The GRA works with Georgia companies through its Technology Partnerships Program, which provides grants to university researchers conducting collaborative research with a Georgia company that will help the company to develop or refine its products and processes. The company matches the grants dollar-for-dollar.

"A major goal of the Georgia Research Alliance is to help Georgia companies tap into the research resources of our universities. This collaboration is an excellent example of how this can lead to new product and market opportunities," says H. Lee Herron, GRA Vice President of Commercialization.

ERTb performs image reconstruction and synthesis, quality control and correction for patient and physical phenomena to provide high-quality myocardial perfusion SPECT images for cardiovascular diagnosis.

SPECT (single photon emission computerized tomography) is a non-invasive, three-dimensional, functional imaging technology that provides clinical information about biochemical and physiologic processes in patients. This is done by imaging and quantifying the distribution of radionuclides in the body that are used to label molecules, drugs, antibodies, neurotransmitters and other compounds. These tracers are used to detect biochemical and physiologic processes that may signal the early progression of coronary artery disease.

ERTb, which can be used on any standalone PC, is designed to be the image generating "front end" for the widely used Emory Cardiac Toolbox™, a vast set of software tools for evaluating cardiac images, developed by Garcia and his colleagues at Emory and elsewhere over the past 20 years. The Emory Cardiac Toolbox is used in almost half of the cardiac laboratories in the United States.

Syntermed will market ERTb as ReconTools, which it will introduce at the American Society of Nuclear Cardiology (ASNC) 2008 annual meeting in Boston, Sept. 10-14. Chen will present research related to new imaging technologies, including ERTb, at the meeting on Saturday, Sept. 13.

"SPECT studies are a critical part of diagnosis and prognosis of coronary artery disease," says Garcia, who is a professor of radiology at Emory University School of Medicine. "As software imaging technologies continue to improve, diagnosis becomes increasingly detailed and accurate. Among other things, the ERTb software was developed to automate the detection and correction of patient motion, reconstruct and synthesize images and correct subtle physical changes that can degrade accuracy in SPECT imaging."

The original Emory Cardiac Toolbox was the founding technology of Syntermed, established in 1999 as an Emory spin-off of research, technology and existing licenses to the major medical imaging companies. Today the Toolbox has five other tools to support 3-D cardiac imaging of heart perfusion, including the recent FDA cleared SyncTool™, which is designed to more accurately select heart failure patients who would benefit from cardiac resynchronization therapy (CRT).

Garcia is the scientific founder and chief scientific advisor of Syntermed. The company is co-owned in part by Emory and Georgia Tech.

Michael Lee, chairman and CEO of Syntermed says, "Syntermed started in the simplest way possible, with the objective to commercialize technology that promotes innovation and creativity. Today, ours' is a success story founded on a strong portfolio of intellectual property licensed from Emory that continues to thrive. We were proud to be the industry partner in the GRA Technology Partnerships Program, which recognizes our ability to launch these innovations into a highly competitive and complex market."


'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Related biology news :

1. Improved estrogen reception may sharpen fuzzy memory
2. Study of marine snail leads to new insights into long-term memory
3. Living fossils have long- and short-term memory
4. Working memory has limited slots
5. Metal foam has a good memory
6. Dolphin therapy a dangerous fad, Emory researchers warn
7. Emory, Ohio State launch partnership in predictive and personalized health care
8. Young chimps top adult humans in numerical memory
9. Emory paleontologist reports discovery of carnivorous dinosaur tracks in Australia
10. UCI researchers restore memory process in most common form of mental disability
11. Simons Foundation awards Emory scientists $3M for autism gene research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2016)... India , January 21, 2016 ... According to a new market research report "Emotion Detection ... and Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020", published by ... is expected to reach USD 22.65 Billion by ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., a ... simplifies the use and access of ubiquitous on-premise ... partnership with American Cyber.  ... experience leading transformational C4ISR and Cyber initiatives in ... the latest proven technology solutions," said Steve ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... 4, 2016 - New FDA action date of ... New FDA action date of July 22, 2016   ... 22, 2016   - Lifitegrast ... decade indicated for the treatment of signs and symptoms of dry ... the potential to be the only product approved in the U.S. in the past decade ...
(Date:2/4/2016)... , Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... commercializing its flagship CytoSorb® blood filter to treat ... around the world, announced that CEO Dr. ... the Source Capital Group,s 2016 Disruptive Growth & ... the company.  Conference Presentation Details: ...
(Date:2/4/2016)... Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... China , today announced that the ... February 4, 2016 a preliminary non-binding proposal letter, dated ... V-Ming ( Shanghai ) Investment Holdings Co., ... Shenzhen ) Fund Management Co., Ltd., Beijing ...
(Date:2/3/2016)... , Feb. 3, 2016  Discovery Laboratories, Inc. ... on developing aerosolized KL4 surfactant therapies for respiratory ... has approved an inducement award as a component ... its newly appointed President and Chief Executive Officer.  ... Committee on February 1, 2016 and granted as ...
Breaking Biology Technology: